Published on 12 Oct 2021 on MSN News
Allogene (ALLO) Falls on FDA Clinical Hold on CAR-T Studies
Allogene Therapeutics, Inc. ALLO announced that the FDA has placed its clinical studies evaluating...
NASDAQ.ALLO price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free